Turning Point Therapeutics, Inc.
TPTXDelisted Aug 17, 2022- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001595893
Turning Point Therapeutics, Inc. was delisted on Aug 17, 2022; its insiders filed their last Form 4 on Aug 17, 2022; 209 institutions reported holding it in 13F filings for Q2 2022, worth $3.29B in total; Soros Fund Management was the only superinvestor holding it.
Superinvestors holding TPTX, Q2 2022
1 superinvestor reports holding Turning Point Therapeutics, Inc. on Form 13F, worth $61.8M in total. Weight is Turning Point Therapeutics, Inc.'s share of each 13F portfolio; actions compare shares with Q1 2022.
| Superinvestor | % of portfolio | Shares | Value | vs. previous quarter |
|---|---|---|---|---|
| Soros Fund ManagementGeorge Soros | 1.2% | 821,635 | $61.8M | New |
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of TPTX each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q2 2022
1 superinvestor holding at quarter end